172 related articles for article (PubMed ID: 10844490)
1. Famotidine in the treatment of acute urticaria.
Watson NT; Weiss EL; Harter PM
Clin Exp Dermatol; 2000 May; 25(3):186-9. PubMed ID: 10844490
[TBL] [Abstract][Full Text] [Related]
2. Histamine H2-receptor antagonists for urticaria.
Fedorowicz Z; van Zuuren EJ; Hu N
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD008596. PubMed ID: 22419335
[TBL] [Abstract][Full Text] [Related]
3. Oral agents in the management of urticaria: patient perception of effectiveness and level of satisfaction with treatment.
Pontasch MJ; White LJ; Bradford JC
Ann Pharmacother; 1993 Jun; 27(6):730-1. PubMed ID: 8329794
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria.
Moscati RM; Moore GP
Ann Emerg Med; 1990 Jan; 19(1):12-5. PubMed ID: 2404434
[TBL] [Abstract][Full Text] [Related]
5. Histamine antagonists in the treatment of acute allergic reactions.
Runge JW; Martinez JC; Caravati EM; Williamson SG; Hartsell SC
Ann Emerg Med; 1992 Mar; 21(3):237-42. PubMed ID: 1536481
[TBL] [Abstract][Full Text] [Related]
6. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists.
Lin RY; Curry A; Pesola GR; Knight RJ; Lee HS; Bakalchuk L; Tenenbaum C; Westfal RE
Ann Emerg Med; 2000 Nov; 36(5):462-8. PubMed ID: 11054200
[TBL] [Abstract][Full Text] [Related]
7. Outpatient management of acute urticaria: the role of prednisone.
Pollack CV; Romano TJ
Ann Emerg Med; 1995 Nov; 26(5):547-51. PubMed ID: 7486360
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with H2 blocker famotidine to ameliorate protamine-induced hypotension in open-heart surgery.
Mayumi H; Toshima Y; Tokunaga K
J Cardiovasc Surg (Torino); 1992; 33(6):738-45. PubMed ID: 1287015
[TBL] [Abstract][Full Text] [Related]
9. On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study.
Holtmeier W; Holtmann G; Caspary WF; Weingärtner U
J Clin Gastroenterol; 2007 Jul; 41(6):564-70. PubMed ID: 17577112
[TBL] [Abstract][Full Text] [Related]
10. A randomized clinical trial of histamine 2 receptor antagonism in treatment-resistant schizophrenia.
Meskanen K; Ekelund H; Laitinen J; Neuvonen PJ; Haukka J; Panula P; Ekelund J
J Clin Psychopharmacol; 2013 Aug; 33(4):472-8. PubMed ID: 23764683
[TBL] [Abstract][Full Text] [Related]
11. Intravenous Cetirizine Versus Intravenous Diphenhydramine for the Treatment of Acute Urticaria: A Phase III Randomized Controlled Noninferiority Trial.
Abella BS; Berger WE; Blaiss MS; Stiell IG; Herres JP; Moellman JJ; Suner S; Kessler A; Klausner HA; Caterino JM; Du J
Ann Emerg Med; 2020 Oct; 76(4):489-500. PubMed ID: 32653333
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.
Wan KS
J Dermatolog Treat; 2009; 20(4):194-7. PubMed ID: 19085267
[TBL] [Abstract][Full Text] [Related]
13. Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines.
Ujiie H; Shimizu T; Natsuga K; Arita K; Tomizawa K; Shimizu H
Clin Exp Dermatol; 2006 Jul; 31(4):588-9. PubMed ID: 16716168
[No Abstract] [Full Text] [Related]
14. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria.
Greene SL; Reed CE; Schroeter AL
J Am Acad Dermatol; 1985 Apr; 12(4):669-75. PubMed ID: 3886724
[TBL] [Abstract][Full Text] [Related]
15. Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.
Hsu PI; Wu DC; Tsay FW; Cheng JS; Liu CP; Lai KH; Chen WC; Wang HM; Tsai TJ; Tsai KW; Kao SS
Am J Gastroenterol; 2017 Feb; 112(2):282-289. PubMed ID: 27922030
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute duodenal ulcers with famotidine and its comparison with other H2 blockers.
Akhtar MA; Rashid P; Khan MA
J Pak Med Assoc; 1990 Jun; 40(6):136-7. PubMed ID: 1975277
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease.
Hongo M; Kinoshita Y; Haruma K
J Gastroenterol; 2008; 43(6):448-56. PubMed ID: 18600389
[TBL] [Abstract][Full Text] [Related]
18. Controlled trial of H1 antagonists in the treatment of chronic idiopathic urticaria.
Sussman G; Jancelewicz Z
Ann Allergy; 1991 Oct; 67(4):433-9. PubMed ID: 1683191
[TBL] [Abstract][Full Text] [Related]
19. Famotidine treatment of children with autistic spectrum disorders: pilot research using single subject research design.
Linday LA; Tsiouris JA; Cohen IL; Shindledecker R; DeCresce R
J Neural Transm (Vienna); 2001; 108(5):593-611. PubMed ID: 11459079
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment.
See MC; Birnbaum AH; Schechter CB; Goldenberg MM; Benkov KJ
Dig Dis Sci; 2001 May; 46(5):985-92. PubMed ID: 11341669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
